XpresTest began conducting bio surveillance monitoring with the Centers for Disease Control and Prevention (CDC) in collaboration with Concentric by Ginkgo Bioworks Holdings, Inc. ("Ginkgo Bioworks")…
XpresTest began conducting bio surveillance monitoring with the Centers for Disease Control and Prevention (CDC) in collaboration with Concentric by Ginkgo Bioworks Holdings, Inc. ("Ginkgo Bioworks")…
Reciprocal relationship from RMTHF graph: Reciprocal relationship from XWEL graph: Reciprocal relationship from RMTHF graph: Reciprocal relationship from XWEL graph: Reciprocal relationship from RMTH…
Turkey. Treat, which is operating through XWELL's subsidiary Treat, Inc. ("Treat") is a wellness brand that provides access to wellness services for travelers at on-site centers.
On May 16, 2025, the Company entered into a sales and marketing agreement with a vendor that obligates the Company to make payments totaling $662 over the next three years.
XpresTest began conducting bio surveillance monitoring with the Centers for Disease Control and Prevention (CDC) in collaboration with Concentric by Ginkgo Bioworks Holdings, Inc. ("Ginkgo Bioworks")…
XWELL, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
XWEL-DEBT-13701
Warrants outstanding: 1942131
90%
xbrl warrant detail from xbrl 2025-12-31.
XWEL-DEBT-13702
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
XWEL-DEBT
Debt stack $12.5M
90%
Market cache reports total debt of $12.5M.
XWELL, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for XWELL, Inc..
XWELL, Inc. Ownership
Holder
Name
Confidence
Evidence
XWEL-OWNER-STRATEGIC-WEALTH-PARTNERS-LTD
Strategic Wealth Partners, Ltd.
90%
13F overlay lists Strategic Wealth Partners, Ltd. as top holder; 2 tracked holders.
